Background: Brief periods of haemoglobin oxygen desaturation are common in children during induction of general anaesthesia. We tested the hypothesis that oxygen insufflation during intubation slows desaturation. Methods: Patients 1-17 yr old undergoing nasotracheal intubation were enrolled and randomly assigned to one of three groups: standard direct laryngoscopy (DL); laryngoscopy with Truview PCD videolaryngoscope (VLO 2 ); or laryngoscopy with an oxygen cannula attached to the side of a standard laryngoscope (DLO 2 ). The co-primary outcomes were time to 1% reduction in S p O2 from baseline, and the slope of overall desaturation vs time. All three groups were compared against each other. Results: Data from 457 patients were available for the final analysis: 159 (35%) DL; 145 (32%) DLO 2 ; and 153 (33%) VLO 2 . Both VLO 2 and DLO 2 were superior to DL in both time to a 1% reduction in S p O2 from baseline and the overall rate of desaturation (all P<0.001). The 25th percentile (95% confidence interval) of time to a 1% saturation decrease was 30 (24, 39) s for DL, 67 (35, 149) s for DLO 2 and 75 (37, 122) s for VLO 2 . Mean desaturation slope was 0.13 (0.11, 0.15)% s −1 for DL, 0.04 (0.02, 0.06)% s −1 for DLO 2 and 0.03
described in adults. 5 Apnoeic oxygenation is based on absorption of oxygen into the bloodstream, with the absorbed pulmonary volume being replaced by fresh oxygen pulled from the larynx through the trachea into the lungs. It thus requires an unobstructed airway. As might therefore be expected, deep laryngeal oxygen insufflation better maintains lung oxygen partial pressure than nasal prongs, which provide a much lower effective inspired oxygen concentration. 6 Laryngoscope blades with an integrated oxygen delivery channel provide deep laryngeal oxygen insufflation during tracheal laryngoscopy. One such device, the Oxyscope, has been commercially available since the early 1980s and is used in neonates and infants. 7 A novel US Food and Drug Administration-approved videolaryngoscope (Truview PCD; Truphatek International Ltd, Netanya, Israel) combines the use of deep laryngeal oxygenation with video technology to facilitate tracheal intubation in infants, children, and adults. [8] [9] [10] The Truview PCD provides a better laryngeal view than standard Miller blades in neonates and infants with normal airways, 8 but its ability to provide deep laryngeal oxygenation has yet to be evaluated formally. It is also unknown whether a special oxygenating blade is necessary, or whether oxygen can be provided equally well with a cannula attached to a conventional blade. We therefore evaluated haemoglobin oxygen saturation (S p O2 ) in paediatric patients during apnoea with or without deep laryngeal oxygen insufflation. Laryngeal oxygen was provided with either a Truview PCD blade (VLO 2 ) or a conventional Miller blade supplemented with an oxygen cannula (DLO 2 ) during nasotracheal intubation. We tested the hypothesis that compared with direct laryngoscopy without supplemental oxygen (DL), deep laryngeal oxygenation with either DLO 2 or VLO 2 delays oxyhaemoglobin desaturation.
Methods
With institutional review board approval, we enrolled patients at Children's Health: Children's Medical Centre Dallas between June 2013 and July 2014. We obtained written consent from parents and written assent from children 10 yr and older. We enrolled children (age 1-17 yr), who had an ASA physical status I-III, who were undergoing dental rehabilitation with general anaesthesia and nasotracheal intubation. We excluded patients with significant cardiorespiratory disease or recent respiratory infection, those at risk for pulmonary aspiration, and those with known or suspected difficult airway.
Protocol
Anaesthesia was induced with sevoflurane 8% in oxygen 100% by face mask. An i.v. cannula was inserted and rocuronium 0.6 mg kg −1 given. Fentanyl and propofol were also available for use at the discretion of the anaesthetist. The sevoflurane concentration was then decreased to 2-2.5%, and subjects were mask ventilated for the next 3 min with 70%-30% N 2 O-O 2 . Subjects were randomly assigned to one of the following three groups: (i) standard direct laryngoscopy (DL); (ii) laryngoscopy with Truview PCD videolaryngoscope (catalogue #4127; Truphatek, Netanya, Israel; VLO 2 ); or (iii) laryngoscopy with an oxygen cannula attached to the side of standard laryngoscope (DLO 2 ). Randomization was based on computer-generated treatment allocations (Research Randomizer, Version 4.0 at http:// www.randomizer.org) that were maintained in sequentially numbered sealed envelopes. Randomization was 1:1:1, without stratification or blocking. The envelopes were opened immediately before induction of anaesthesia.
Laryngoscopy was performed routinely in the DL group. In the VLO 2 group, oxygen was insufflated through the integrated channels in the blades at a rate of 2 litre min After preoxygenation, the face mask was removed and the designated laryngoscope blade immediately inserted into the patient's mouth. Nasotracheal intubation was accomplished using the technique described by Watt and colleagues. 11 Briefly, a nasal RAE tracheal tube (Mallinckrodt, Pleasanton, CA, USA) was telescoped into a size 10 or 12 F red rubber catheter as it passed from the naris into the pharynx. Magill forceps were then used to retrieve the red rubber catheter and facilitate placement of the nasotracheal tube tip into the trachea under direct vision or video guidance. Once the trachea was intubated, correct placement of the tracheal tube was confirmed with end-tidal CO 2 . The study was stopped when: (i) the trachea was intubated and a capnography trace obtained; (ii) oxygen saturation decreased to 90%; or (iii) signs of cardiac instability were evident. Tracheal intubation was not delayed for study purposes.
Measurements
In addition to standard ASA safety monitoring, a second S p O2 probe (Pulse Co-Oximeter Sensor-R1 25L; Masimo Corporation, Irvine, CA, USA) was positioned on each subject's toe before induction of anaesthesia and connected to a Masimo Radical 7 (Masimo Corporation, Irvine, CA, USA) monitor. The signal IQ bar indicator on the Radical 7 monitor was observed throughout the data recording for high-quality signal. No low-quality data were recorded. The S p O2 values from the Co-Oximeter sensor were recorded at 1 s intervals by a computer attached to the Radical 7 from the beginning to the end of laryngoscopy. Laryngoscopy time was recorded, as was the interval from cessation of mask ventilation until the tracheal tube was advanced past the vocal cords and a valid CO 2 trace confirmed tracheal placement.
After collecting data for the first interim analysis, we noticed that the rate of desaturation was not constant (time-S p O2 relationship was non-linear) during intubation and usually increases over time, which is apparent in the two figures displaying individual subject saturation data in a Supplementary Figure S1 . In many instances, saturation remains stable before a linear reduction in saturation. This was the reason we chose to describe the desaturation during the intubation using the following two Editor's key points
• Haemoglobin oxygen desaturation is common and rapid in children during laryngoscopy for tracheal intubation.
• The effect of oxygen insufflation on pulse oximetry measurements during laryngoscopy was studied in 457 children undergoing nasotracheal intubation.
• Deep insufflation of oxygen slowed desaturation when used with either direct or video-assisted laryngoscopy compared to direct laryngoscopy alone.
Laryngeal oxygenation during apnoea in children | 351 primary outcomes for each subject. The time to 1% decrease in S p O2 from baseline was calculated as the elapsed time (in seconds) between baseline (S p O2 in the first second of intubation) and a reduction of 1% in S p O2 (e.g. from 100 to 99%). Overall desaturation rate was assessed based on repeated second-by-second S p O2 measurements, and is intended to describe the average rate of S p O2 decrease, ignoring non-linearity of the S p O2 -time relationship. Desaturation rate is the slope coefficient of the linear trend of desaturation throughout the laryngoscopy period, measured as the percentage per second (see 'Statistical analysis' for more details). Previous studies on desaturation also reported a linear desaturation rate, making our methods consistent with the literature. Subject characteristics, airway assessment, and anaesthetic information were recorded. Blood pressure and heart rate were recorded before laryngoscopy and at 1 min intervals for 10 min starting at the time of laryngoscopy.
Statistical analysis
We followed a modified intent-to-treat approach, which we define as including for analysis all randomized subjects who received any of the study interventions.
Primary outcomes Desaturation was characterized using two outcomes: time to a 1% decrease in S p O2 from baseline; and overall rate (slope) of desaturation over time. We considered a given intubation technique (DLO 2 or VLO 2 ) better than DL if it was found to be non-inferior (i.e. not worse) on both outcomes and superior on at least one. We defined a priori the noninferiority Δ for time to 1% reduction as 5 s [or 1.05 if using hazard ratio (HR)] and for desaturation slope as 0.05% s −1 .
We used joint hypothesis testing to control type I error at 0.025 across all noninferiority and superiority testing 12 comparing VLO 2 and DLO 2 with DL on primary outcomes. Given that noninferiority was required for both outcomes, no Bonferroni correction was made [α=0.025, 95% confidence intervals (CIs)]. However, Bonferroni correction was used for superiority testing because superiority on either outcome (given noninferiority on both) was sufficient (α=0.0125, 97.5% CI). We further adjusted for interim analyses and two pairwise comparisons within primary hypotheses (VLO 2 vs DL and DLO 2 vs DL). We call these the 95% CI for noninferiority and 97.5% CI for superiority. We first estimated the treatment effect (CI) for each outcome. We used Cox proportional hazards regression to compare groups on time to 1% saturation decrease, estimating a hazard ratio for VLO 2 and DLO 2 vs DL, and censoring at intubation if saturation never reduced more than 1%. We reported 25th percentile Kaplan-Meier estimates for 1% saturation decrease from baseline instead of the 50th percentile (median) because many subjects never decreased by 1%. We used a random slope mixed-effects model with repeated measures to assess the treatment effect on overall rate of desaturation, adjusting for within-subject correlation (autoregressive) and restricted to saturations before reaching 90%. We then evaluated noninferiority of VLO 2 and DLO 2 to DL on each outcome. Noninferiority vs DL was claimed for an outcome at the 0.025 significance level if the upper limit of the 95% CI was below the corresponding noninferiority Δ. Second, if noninferiority was concluded for both outcomes, we proceeded to one-tailed superiority tests on each.
A post hoc analysis assessed whether differences between the three laryngoscopy methods on the primary outcomes depended on subject age. Specifically, we assessed the interaction between age and study group in both Cox proportional hazards regression (time to 1% reduction in saturation outcome) and random slope mixed effects (overall saturation rate outcome) models used in the primary analysis.
Secondary analyses
We compared VLO 2 and DLO 2 on each primary outcome using the same methods described above. We also compared groups on mean desaturation slope after an initial 1% reduction from baseline using a random slope model as above, including only saturations before reaching 90%. We compared groups on the proportion reaching 90% saturation using two-tailed χ 2 tests for superiority. We evaluated the association between time to 1% reduction in saturation from baseline and age and BMI using Cox regressions. 13 Type I error was restricted to 5% for secondary analyses using Bonferroni correction. Interim analyses were planned at every 25% of maximal planned enrolment using a group sequential design testing efficacy and futility. We used a γ spending function (γ=−4 for efficacy, −2 for futility) to maintain the significance level for primary hypotheses at 0.025 and power at 90%.
Sample size considerations Sample size was based on assessing superiority on the primary outcome of time to 1% reduction in saturation from baseline because this analysis required more subjects than the rate of desaturation. Assuming a median time to event of 35 s for DL (based on preliminary data) and an exponential distribution, a per-group sample size of 169 was needed to detect a hazard ratio of 0.65 compared with DL at the 0.00625 significance level (0.0125/2 pairwise comparisons) with 90% power. Adjusting for interim analyses gave a total of n=546.
Results
Among 1518 patients screened for eligibility, 482 patients were randomized (Fig. 1) . According to modified intent to treat, 25 subjects were excluded because they did not receive the study intervention, for the following reasons: equipment or software failure (n=21), vomiting during induction (n=2), lack of resources (n=1), and withdraw of consent (n=1).
Seven subjects (1.5%) crossed over to DL and were included and analysed according to their randomized allocation, again according to modified intent to treat: n=2 DLO 2 subjects underwent DL because of improper blade size choice and because of complications from taping the oxygen cannula to the blade; n=5 VLO 2 subjects underwent DL because of vomiting (n=1), lack of space to manoeuvre the tracheal tube in the airway (n=2), or difficulty in obtaining a view (n=2).
Interim analyses were conducted after enrolment of 142, 263, and 393 total subjects to assess efficacy and futility (Fig. 2) . By 263 subjects, the primary outcome comparisons had all crossed into the efficacy region. Recruitment continued to increase precision of the treatment effects; final enrolment was a total of 482 subjects.
Data from 457 subjects were available for final analysis, as follows: 159 (35%) randomized to DL, 145 (32%) randomized to DLO 2 , and 153 (33%) randomized to VLO 2 . The randomized groups were visually balanced on baseline variables (Table 1) ; thus, no baseline variables were included as covariables in the analyses.
Primary outcomes
Both DLO 2 and VLO 2 were found to be noninferior to DL on both primary outcomes, namely the time to 1% decline and overall slope (all P<0.001). We thus proceeded with one-tailed superiority testing and found that both DLO 2 and VLO 2 were also superior to DL on both outcomes (all P<0.001; Table 2 and Fig. 3 ). Hazard ratio estimates indicated that VLO 2 (HR 0.18) and DLO 2 (HR 0.16) were considerably slower and less likely to decrease 1% from baseline compared with DL (Table 2 ). Estimated overall desaturation slope was ∼0.10 slower for each group vs DL ( Table 2) . We therefore conclude for our primary hypothesis that VLO 2 and DLO 2 techniques are each more effective than DL intubation, because superiority was found for both outcomes in each comparison. KaplanMeier curves of time to 1% saturation reduction from the baseline are given in Fig. 4 . A figure displaying individual saturation data by randomized group is reported in a Supplementary Figure S2 .
In a post hoc analysis, we found no evidence of interaction between age and study group for either primary outcome (P-value of 0.76 for time to 1% reduction in saturation and 0.56 for overall desaturation rate). 
Efficacy

Secondary outcomes
The VLO 2 and DLO 2 groups did not differ on either the time to 1% reduction in saturation (P=0.63) or the overall desaturation rate (P=0.26; Table 2 ). The desaturation rate (slope) after the initial 1% reduction in DL subjects (n=142) was significantly higher than for VLO 2 (n=57) and DLO 2 (n=40; both P<0.001). No difference in desaturation rate after the initial 1% reduction was found between DLO 2 and VLO 2 groups (P=0.08; Table 2 ). The risk of desaturation (yes or no) was significantly lower for DLO 2 and VLO 2 compared with DL (both P<0.001; Table 2 ). The DLO 2 and VLO 2 groups did not differ on desaturation incidence (P=0.70). The time to 1% reduction in saturation from baseline was not associated with BMI [based on only n=225 because of missing BMI data, P=0.92, estimated HR for increase of 5 kg m 
Discussion
Our original primary hypothesis was that time to reach S p O2 of 90% was prolonged by supplemental oxygen. But upon reviewing results of the first interim analysis, it became apparent that very few subjects in the oxygenated groups reached S p O2 of 90%, creating serious issues for analysis and interpretation. We thus replaced the original primary outcome with co-primary measures of desaturation.
A 1% decrease in S p O2 from baseline, although not clinically significant, is a harbinger of a more rapid desaturation to come. Both the 1% decrease in saturation from baseline and the rate of desaturation should be considered together when comparing different intubation techniques.
We chose to use a starting oxygen concentration of 30% and nasotracheal intubations in an effort to simulate situations of prolonged intubations in the face of limited O 2 supply and maintain oxygen saturation closer to the inflection of the haemoglobin-oxygen dissociation curve. When we were designing the study, we found that very few patients preoxygenated with 100% oxygen desaturated, even when no supplemental oxygen was given. At a time when the fundamental use of oxygen is being questioned, 14 the authors felt that administering 30% oxygen and having as prerequisite to stop the study when saturation reaches 90% provided a reasonable level of safety. Subjects in both the deep laryngeal oxygenation groups (DLO 2 and VLO 2 ) took on average more than twice as long to desaturate 1% as subjects intubated conventionally (∼70 vs 30 s). The difference between laryngoscopy with and without supplemental oxygen was both highly significant statistically and of clinical importance. Furthermore, the rate of overall desaturation was three-to four-fold faster without supplemental oxygen, again a difference that was both highly significant and of clear clinical importance.
There was, however, no important difference between the two oxygenation approaches for either the time to 1% desaturation or the overall desaturation rate. Our results indicate that even an ad hoc system of providing deep laryngeal oxygen during intubation is sufficient. Previous apnoeic oxygenation studies have used a nasal cannula. 15 Oxygen insufflation through conventional nasal prongs is suboptimal, because the effective fractional inspired O 2 is low and proximal airway obstruction can prevent the open column of gas into the trachea. 16 Cook and colleagues 17 evaluated blood oxygen partial pressure during apnoeic oxygenation via a tracheal tube in 28 paediatric patients. They reported that O 2 partial pressure decreased 4.1 (95% CI 2.7, 5.6) kPa min −1 , which is more than three times the rate reported in adults. 18 They further concluded that after adequate preoxygenation, apnoeic oxygenation maintained adequate saturation in children for at least 10 min. Kernisan and colleagues 19 found that after preoxygenation, apnoeic oxygenation with an oxygen flow of merely 0.1 litre kg −1 min −1 prevented desaturation for 3 min, whereas desaturation otherwise occurred after 116 s in patients weighing <10 kg and in 217 s in those weighing >20 kg. 19 Based on a study on 61 patients between 1 month and 12 yr of age, Kinouchi and colleagues 3 concluded that S p O2 decreases to 95% more quickly in younger than in older children. Although we did not identify an association between age or BMI and desaturation, our study included only a narrower range of each and was not powered for either outcome. Available data nonetheless suggest that use of apnoeic oxygenation in younger patients is less effective, probably because they have an increased oxygen consumption on a per kilogram basis compared with adults. Table 2 Results for primary and secondary outcomes. For the primary analysis, we compared VLO 2 and DLO 2 with DL on two outcomes: time to 1% reduction in saturation from baseline using Cox proportional hazard model; and overall desaturation rate (slope) via linear mixed effects model with repeated measures. For secondary analyses, the VLO 2 and DLO 2 groups were compared using similar models to those for the primary analysis; overall desaturation rate results are reported as the difference in mean slopes using the linear mixed effects model; for the incidence of desaturation (S p O2 <90%) as desaturation relative risk using Pearson's χ 2 test; for the age and BMI effect, the desaturation hazard ratio is reported for an increase of one unit in age or BMI using the Cox proportional hazard model. CI, confidence interval; DL, direct laryngoscopy alone; DLO 2 , direct laryngoscopy with cannula; VLO 2 , Truview PCD laryngoscope; Sp O 2 , haemoglobin oxygen saturation. *Kaplan-Meyer estimate 25th percentile along with adjusted 95% confidence limits were reported instead of the usual 50th percentile (median) because there were insufficient noncensored data for the DLO 2 group (not many patients experienced 1% reduction in S p O2 from their baseline). † Model-based mean slope estimates and difference in mean slopes were reported. ‡ Median laryngoscopy time was reported as the median [first quartile, third quartile], in seconds.
¶ Confidence limits reflect the Bonferroni adjustment for multiple pairwise comparisons, correction for several primary and secondary outcomes, and adjustment for five interim analyses in order to maintain the overall type I error rate at 2.5% for the primary and 5% for the secondary outcomes; all the reported CIs correspond to superiority tests. § Significant P-values corresponding to superiority tests. To our knowledge, this is the first report of use of the Truview PCD for nasal intubations in paediatric patients. We were unable to intubate four subjects (2.5%) assigned to the Truview PCD system, each of whom was subsequently intubated easily after conversion to direct laryngoscopy, a finding consistent with previous publications. 10 A limitation of our analysis is that the primary outcome 'overall desaturation rate' was used to describe desaturation data, ignoring non-linearity of the S p O2 -time relationship. That was done to simplify interpretation and make the results comparable to previously published ones.
In summary, deep laryngeal oxygen insufflation, whatever the delivery method, more than doubles the time to a 1% decrease in S p O2 and reduces the overall rate (slope) of desaturation by more than a factor of three in apnoeic children. There is little cost or risk in providing supplemental laryngeal oxygen during intubation, and it provides clinically important protection against hypoxaemia. We thus recommend that deep laryngeal oxygenation should be considered when intubating children, especially those with limited reserves. 
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